Flomoxef

This classification denotes a cephalosporin antibiotic with the molecular formula C15H18F2N6O7S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V9E5U5XF42, chemically known as (-)-(6r,7r)-7-(2-((difluoromethyl)thio)acetamido)-3-(((1-(2-hydroxyethyl)-1h-tetrazol-5-yl)thio)methyl)-7-methoxy-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid but generally known as flomoxef, which bears US NIH Compound Identifier 65864. European Medicines Agency schedules Flomoxef in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07646MIG. The term FLOMOXEF is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). FLOMOXEF is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flomoxef under HS 29419000 and SITC 54139. As of Q4 2014, FLOMOXEF remains the US FDA Preferred Term for this commodity. Flomoxef bears US NLM identifiers UMLS ID C0117881 and NCI Concept Code C65693. SMILES: S(CC1=C(N2C(OC1)C(OC)(NC(=O)CSC(F)F)C2=O)C(=O)O)C1N(NNN1)CCO.